Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Boehringer Ingelheim’s US Headquarters

Order Year

2011

Project Type

Expansion

Location

Ridgefield, Connecticut

Estimated Investment

$42.5m on safety assessment building, $65m on R&D facility

Sponsor

Boehringer Ingelheim

Output Chemicals

Active pharmaceutical ingredients for drugs in development phases one and two
Expand

Go Top